1-(7-bromo-1H-indol-3-yl)ethanone – (944086-09-3)

Peficitinib, ASP015K, 944118-01-8, Peficitinib free base, ASP-015K, JNJ-54781532, Peficitinib [USAN:INN], HPH1166CKX, ASP 015K, Peficitinib [USAN], PEFICITINIB [INN], PEFICITINIB [WHO-DD], 4-[[(1R, 3S)-5-hydroxy-2-adamantyl]amino]-1H-pyrrolo[2, 3-b]pyridine-5-carboxamide, CHEMBL5424861, DTXSID801319101, 944118-01-8 (free base), 4-(((1R, 2r, 3S, 5s, 7s)-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo[2, 3-b]pyridine-5-carboxamide, 4-((Trans-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo(2, 3-b)pyridine-5-carboxamide, 4-((5-hydroxy-2-adamantyl)amino)-1H-pyrrolo(2, 3-b)pyridine-5-carboxamide, 4-((ANTI-5-HYDROXYADAMANTAN-2-YL)AMINO)-1H-PYRROLO(2, 3-B)PYRIDINE-5-CARBOXAMIDE, 4-[[(1S, 3R)-5-oxidanyl-2-adamantyl]amino]-1H-pyrrolo[2, 3-b]pyridine-5-carboxamide, 4-(((1R, 2s, 3S, 5s, 7s)-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo(2, 3-b)pyridine-5-carboxamide, UNII-HPH1166CKX, peficitinibum, 4-(((1R, 2s, 3S, 5r)-5-hydroxyadamantan-2-yl)amino)-1H-pyrrolo(2, 3-b)pyridine-5-carboxamide, 4-(((1R, 3S)-5-hydroxy-2-adamantyl)amino)-1H-pyrrolo(2, 3-b)pyridine-5-carboxamide, 4-{[(1R, 2s, 3S, 5r)-5-hydroxyadamantan-2-yl]amino}-1H-pyrrolo[2, 3-b]pyridine-5-carboxamide, 9T6, Peficitinib (Standard), Peficitinib (USAN/INN), GTPL8315, SCHEMBL1154418, SCHEMBL1154421, SCHEMBL4447032, SCHEMBL9990240, SCHEMBL9990248, CHEMBL3137308, SCHEMBL17645135, DTXCID801748057, DTXSID701111132, BCP18465, BDBM50124208, BDBM50622128, HY-19568R, PEFICITINIB HYDROBROMIDE [JAN], CS-5393, DB11708, PeficitinibASP015K, JNJ-54781532, HY-19568, MS-24878, PeficitinibASP015K, JNJ-54781532?, ASP015K JNJ-54781532, NS00073757, D10653, BRD-K21225231-001-01-2, Q27088288, 1H-Pyrrolo(2, 3-b)pyridine-5-carboxamide, 4-((5-hydroxytricyclo(3.3.1.13, 7)dec-2-yl)amino)-, stereoisomer, 944134-74-1, Stereoisomer of 4-[(5-hydroxytricyclo[3.3.1.13, 7]dec-2-yl)amino]-1H-pyrrolo[2, 3-b]pyridine-5-carboxamide